Healthcare AI companyCerviGuard live productDataGems live research pilot

Clinician-led AI workflow software for cervical screening.

SmartClover builds healthcare AI where clinical work actually happens. Our flagship product, CerviGuard, helps cervical-screening teams structure intake, review cases with AI support, coordinate triage, and manage clinician-led follow-up. DataGems supports our synthetic-data research track.

  • Product proof:live product surface at cerviguard.link plus public repository and model hub references.
  • Research context:PubMed references from 2017 and 2022 provide context on cervical screening participation and follow-up work.
  • Trust orientation:privacy, security, incident response, pricing, buying, proof, and regulatory routes remain public.
CerviGuard dashboard showing case distribution and operational overview
Authentic flagship proofThe live CerviGuard workspace shows case review, operational oversight, and clinician-led follow-up workflows.
1

Visitors can review CerviGuard through its live workspace, public repository, screenshots, and trust material.

1

DataGems gives research partners a concrete surface for synthetic-data workflow discussions.

2

PubMed references provide cervical-screening context for readers who want the research background.

Product evidence and working routes

SmartClover links the live CerviGuard workflow to research context, trust material, and direct commercial paths for clinics, research partners, and investors.

Live product

CerviGuard is the flagship product.

The live product surface, public repository, and trust routes make the cervical screening workflow visible from the first visit.

Research context

Cervical-screening research is easy to find.

Two PubMed references are linked for visitors who want context on cervical screening participation and follow-up work in Romania.

Trust routes

Security, privacy, proof, and regulatory material stay visible.

Visitors can move from the homepage into trust, proof, pricing, and buying paths without leaving the public site.

A flagship product within a broader company platform

CerviGuard is the product teams review first. DataGems, research, and trust surfaces show the broader SmartClover work around it.

Flagship product

CerviGuard

A live product for structured cervical screening workflows, AI-assisted review, and clinician-led follow-up.

Live research pilot

DataGems

A live research pilot for synthetic-data generation using SLM-first execution with optional external APIs.

Public research directions

Cancer prevention and decision support

SmartClover publicly discusses cancer prevention, secondary prophylaxis, early detection, and treatment-optimization research as active directions, not as released products.

Founder and research credibility

Built around cervical-screening work, not generic AI positioning.

Founder Dr. Andreea Damian leads SmartClover from Cluj-Napoca with CerviGuard as the flagship product. The research links below are kept as context for the cervical-screening problem space; current product details come from CerviGuard, product, and trust pages.

PubMed 35197342 covers follow-up barriers after abnormal cervical screening results.PubMed 28460211 covers barriers to cervical screening participation in Romania.CerviGuard, GitHub, Hugging Face, and trust routes are available before outreach.
Research workspace representing SmartClover's cervical-screening context
Research context and product proofResearch links, product access, and trust materials give visitors concrete places to continue.

Public timeline of research, productization, and company development

The homepage shows the public milestones that connect research, productization, and transparent company execution.

2017 publication

Screening participation barriers documented

Social Science & Medicine published field research on Roma women and cervical screening participation in Romania.

2022 publication

Follow-up barriers researched in remote communities

BMJ Open published a protocol on facilitators and barriers to follow-up after abnormal cervical screening results in remote Romanian communities.

2024-2026 product build-out

CerviGuard moved into a live product surface

The public product surface, repository, and model hub provide a concrete flagship proof layer with supporting artifacts.

Current routes

Choose the right conversation

Contact, pricing, how-to-buy, proof, regulatory, and trust routes help each visitor decide where to start.

Clear next steps for buyers, partners, and investors

The site keeps one primary CTA while making audience-specific entry points clear for buyers, partners, and investors.

Book demo / Request pilot

For clinics, hospitals, and operators evaluating CerviGuard or a scoped product rollout.

Go to contact hub

Research partnership

For institutions exploring prevention, qualitative research, or model-development collaboration.

Go to contact hub

Investor inquiry

For investors or accelerators reviewing SmartClover's healthcare AI platform, public proof, and commercial readiness.

Go to contact hub

Use these routes to review proof, regulatory posture, trust, pricing, and procurement context before outreach.